Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × NSCLC × Clear all

Phase

Phase 2 13 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Unknown 3 Completed 3 Recruiting 2 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 22 Neoplasms 11 Rectal Neoplasms 10 Lung Neoplasms 10 Leukemia, Myeloid, Acute 10 Colorectal Neoplasms 10 Nasopharyngeal Carcinoma 8 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Small Cell Lung Carcinoma 7 Carcinoma, Hepatocellular 7 Ovarian Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 6 Glioblastoma 6 Esophageal Squamous Cell Carcinoma 6 Recurrence 5 Prostatic Neoplasms 5 Esophageal Neoplasms 5 Carcinoma, Renal Cell 5 Brain Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Lymphoma, Follicular 3 Endometrial Neoplasms 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07376382 2026-02-02

SYNSTAR-02

CSPC Megalith Biopharmaceutical Co.,Ltd.

Phase 3 Not yet recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡